Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Zoetis Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - PharmaceuticalsSector: Healthcare

Fair Value Summary

Current Price$119.34
5Y Range86.74 – 137.16
5Y Selected111.95
(-) Safety Margin22.80%
5Y Buy Price$86.43
Upside (to Buy Price)-27.58%
10Y Range98.71 – 151.71
10Y Selected125.21
(-) Safety Margin22.80%
10Y Buy Price$96.66
Upside (to Buy Price)-19.00%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9598
Revenue R2 (10Y)0.9816
Net Income R2 (5Y)0.9478
Net Income R2 (10Y)0.9707
EBITDA R2 (5Y)0.9709
EBITDA R2 (10Y)0.9785
FCF R2 (5Y)0.2571
FCF R2 (10Y)0.7652
Safety Score0.7720

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth8.45%7.95%7.46%6.96%6.47%5.98%5.48%4.99%4.49%4.00%
Revenue10,037.7510,835.9511,644.0812,454.9713,260.8014,053.2614,823.6615,563.0616,262.4616,912.96
EBITDA4,333.634,678.245,027.145,377.235,725.136,067.266,399.876,719.097,021.057,301.89
D&A-557.64-601.98-646.87-691.92-736.69-780.71-823.51-864.59-903.44-939.58
EBIT3,776.004,076.264,380.274,685.314,988.445,286.555,576.365,854.516,117.616,362.31
Pro forma Taxes-837.79-904.41-971.86-1,039.54-1,106.80-1,172.94-1,237.24-1,298.95-1,357.33-1,411.62
NOPAT2,938.213,171.853,408.413,645.773,881.654,113.614,339.124,555.554,760.284,950.69
Capital Expenditures-650.30-702.01-754.37-806.90-859.11-910.45-960.36-1,008.26-1,053.57-1,095.72
NWC Investment-193.05-197.11-199.56-200.24-198.99-195.69-190.24-182.59-172.71-160.64
(+) D&A557.64601.98646.87691.92736.69780.71823.51864.59903.44939.58
Free Cash Flow2,652.502,874.713,101.353,330.543,560.233,788.184,012.034,229.294,437.444,633.92
Diluted Shares Outstanding446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00446,950,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.49%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF2,629.502,761.842,731.102,688.352,634.102,569.022,493.932,409.742,317.502,218.29
Raw: 55,226.28
39,119.32
Raw: 71,881.29
32,944.08

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value52,564.2158,397.46
(-) Net Debt5,083.255,083.25
Equity Value47,480.9653,314.21
(/) Shares Out446.95446.95
Fair Value$106.23$119.28
(-) Safety Margin22.80%22.80%
Buy Price$82.01$92.09
Current Price$119.34$119.34
Upside (to Buy Price)-31.28%-22.84%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.99%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF2,627.102,750.272,694.962,628.682,552.242,466.582,372.732,271.812,165.002,053.50
Raw: 44,788.70
30,600.04
Raw: 58,295.97
24,620.39

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value43,853.2949,203.26
(-) Net Debt5,083.255,083.25
Equity Value38,770.0444,120.01
(/) Shares Out446.95446.95
Fair Value$86.74$98.71
(-) Safety Margin22.80%22.80%
Buy Price$66.97$76.21
Current Price$119.34$119.34
Upside (to Buy Price)-43.89%-36.14%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.99%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF2,631.922,773.562,768.072,749.942,719.382,676.732,622.522,557.442,482.292,398.01
Raw: 71,794.96
52,744.36
Raw: 93,446.70
46,511.22

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value66,387.2372,891.09
(-) Net Debt5,083.255,083.25
Equity Value61,303.9867,807.84
(/) Shares Out446.95446.95
Fair Value$137.16$151.71
(-) Safety Margin22.80%22.80%
Buy Price$105.89$117.12
Current Price$119.34$119.34
Upside (to Buy Price)-11.27%-1.86%

Reverse DCF: Market Implied Growth

Current Price$119.34
WACC Used9.1%
IMPLIED REVENUE GROWTH149.44%
Metric2027202820292030203120322033203420352036
Implied Revenue23,439.7358,467.71145,840.98363,783.51907,416.042,263,444.765,645,902.1214,083,052.2435,128,550.9587,624,122.33
Constant Implied Growth149.44%149.44%149.44%149.44%149.44%149.44%149.44%149.44%149.44%149.44%
Implied Free Cash Flow2.345.8514.5836.3890.74226.34564.591,408.313,512.868,762.41
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF2.184.7210.7924.6756.41128.97294.86674.171,541.393,524.20

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$132.358.68%$51.28-61.25%
20182018-12-31$85.548.99%$56.56-33.88%
20172017-12-31$72.049.39%$44.68-37.98%
20162016-12-31$53.539.81%$15.44-71.16%
20152015-12-31$47.928.96%$12.05-74.85%
20142014-12-31$43.038.35%$13.07-69.62%
20132013-12-31$32.695.94%$13.27-59.40%
20122012-12-31$31.013.76%$11.11-64.18%
20112011-12-31$31.013.01%$11.97-61.41%
20102010-12-31$31.012.45%$3.20-89.68%
20092009-12-31$31.015.15%$-1.46-104.70%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$122.86
Median
$119.24
10th Percentile
$97.56
90th Percentile
$152.44

Fair Value Distribution

$79.29 - $91.27
44
$91.27 - $103.25
141
$103.25 - $115.23
242
$115.23 - $127.21
211
$127.21 - $139.19
161
$139.19 - $151.17
94
$151.17 - $163.15
49
$163.15 - $175.13
36
$175.13 - $187.11
10
$187.11 - $199.09
0
$199.09 - $211.07
4
$211.07 - $223.05
2
$223.05 - $235.03
4
$235.03 - $247.02
1
$247.02 - $259.00
0
$259.00 - $270.98
0
$270.98 - $282.96
0
$282.96 - $294.94
0
$294.94 - $306.92
0
$306.92 - $318.90
1